Akihiko Urayama
Assistant Professor
Department of Neurology
The University of Texas Health Science Center
United States of America
Biography
Dr. Urayama received his research doctorate in Pharmacology from the University of Shizouka in Japan. He completed Post-Doctoral Fellowships in Internal Medicine and Neurology respectively at the Saint Louis University School of Medicine and the University of Texas Medical School at Houston. He was trained by one of the world’s leaders in blood-brain barrier (BBB) function, Dr. William Banks. He then completed a fellowship and joined the faculty under the mentorship of Dr. Claudio Soto. He learned a great deal through them, and acquired expertise in many different areas, including the BBB and neurodegenerative diseases such as lysosomal storage, Alzheimer’s, and prion diseases. Currently, Dr. Urayama is affiliated with the cerebrovascular group where he continues investigating the role of the BBB in health and disease. Dr. Urayama is a well-recognized investigator who has constantly given presentations in national and international conferences in his research fields, and his roles include invited speaker and plenary session presenter. Dr. Urayama has been an effective educator and research mentor for Medical and Graduate School students. He is enthusiastic about teaching introductory and advanced courses with current hypothesis, logic, and proof theory behind biomedical topics. He publishes his research work in first class journals, and serves as a reviewer for professional journals, and research foundations.
Research Interest
Blood-Brain Barrier and Neurological disorders
Publications
-
Urayama A, Dohgu S, Robinson SM, Sly WS, Grubb JH, Banks WA. Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier. PloS one. 2015; 10(11):e0142347.
-
Urayama A, Grubb JH, Sly WS, Banks WA. Pharmacologic manipulation of lysosomal enzyme transport across the blood-brain barrier. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2016; 36(3):476-86.
-
Urayama A, Concha-Marambio L, Khan U, Bravo-Alegria J, Kharat V, Soto C. Prions efficiently cross the intestinal barrier after oral administration: Study of the bioavailability, and cellular and tissue distribution in vivo. Scientific reports. 2016; 6:32338.